95 related articles for article (PubMed ID: 8923876)
1. Absence of the previously reported G protein oncogene (gip2) in ovarian granulosa cell tumors.
Shen Y; Mamers P; Jobling T; Burger HG; Fuller PJ
J Clin Endocrinol Metab; 1996 Nov; 81(11):4159-61. PubMed ID: 8923876
[TBL] [Abstract][Full Text] [Related]
2. Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors.
Fragoso MC; Latronico AC; Carvalho FM; Zerbini MC; Marcondes JA; Araujo LM; Lando VS; Frazzatto ET; Mendonca BB; Villares SM
J Clin Endocrinol Metab; 1998 Jun; 83(6):2074-8. PubMed ID: 9626141
[TBL] [Abstract][Full Text] [Related]
3. Analysis of mutations in genes of the follicle-stimulating hormone receptor signaling pathway in ovarian granulosa cell tumors.
Ligtenberg MJ; Siers M; Themmen AP; Hanselaar TG; Willemsen W; Brunner HG
J Clin Endocrinol Metab; 1999 Jun; 84(6):2233-4. PubMed ID: 10372736
[TBL] [Abstract][Full Text] [Related]
4. No evidence for oncogenic mutations in guanine nucleotide-binding proteins of human adrenocortical neoplasms.
Reincke M; Karl M; Travis W; Chrousos GP
J Clin Endocrinol Metab; 1993 Nov; 77(5):1419-22. PubMed ID: 8077343
[TBL] [Abstract][Full Text] [Related]
5. No evidence of a role for mutations or polymorphisms of the follicle-stimulating hormone receptor in ovarian granulosa cell tumors.
Fuller PJ; Verity K; Shen Y; Mamers P; Jobling T; Burger HG
J Clin Endocrinol Metab; 1998 Jan; 83(1):274-9. PubMed ID: 9435455
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic mutations of alpha-Gi2 protein are not determinant for human adrenocortical tumourigenesis.
Gicquel C; Dib A; Bertagna X; Amselem S; Le Bouc Y
Eur J Endocrinol; 1995 Aug; 133(2):166-72. PubMed ID: 7655640
[TBL] [Abstract][Full Text] [Related]
7. Expression status and mutational analysis of the ras and B-raf genes in ovarian granulosa cell and epithelial tumors.
Jamieson S; Alexiadis M; Fuller PJ
Gynecol Oncol; 2004 Dec; 95(3):603-9. PubMed ID: 15581971
[TBL] [Abstract][Full Text] [Related]
8. Activation of the ERK/MAPK pathway by an isoform of rap1GAP associated with G alpha(i).
Mochizuki N; Ohba Y; Kiyokawa E; Kurata T; Murakami T; Ozaki T; Kitabatake A; Nagashima K; Matsuda M
Nature; 1999 Aug; 400(6747):891-4. PubMed ID: 10476970
[TBL] [Abstract][Full Text] [Related]
9. Regulation of cell proliferation by G proteins.
Dhanasekaran N; Tsim ST; Dermott JM; Onesime D
Oncogene; 1998 Sep; 17(11 Reviews):1383-94. PubMed ID: 9779986
[TBL] [Abstract][Full Text] [Related]
10. Activating mutations of the stimulatory g protein in juvenile ovarian granulosa cell tumors: a new prognostic factor?
Kalfa N; Ecochard A; Patte C; Duvillard P; Audran F; Pienkowski C; Thibaud E; Brauner R; Lecointre C; Plantaz D; Guedj AM; Paris F; Baldet P; Lumbroso S; Sultan C
J Clin Endocrinol Metab; 2006 May; 91(5):1842-7. PubMed ID: 16507630
[TBL] [Abstract][Full Text] [Related]
11. Bidirectional regulation of c-fos promoter by an oncogenic gip2 mutant of G alpha i2. A novel implication of retinoblastoma gene product.
Ikezu T; Okamoto T; Murayama Y; Okamoto T; Homma Y; Ogata E; Nishimoto I
J Biol Chem; 1994 Dec; 269(50):31955-61. PubMed ID: 7989371
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity at the alpha-inhibin locus on chromosome 2q is not a feature of human granulosa cell tumors.
Watson RH; Roy WJ; Davis M; Hitchcock A; Campbell IG
Gynecol Oncol; 1997 Jun; 65(3):387-90. PubMed ID: 9190962
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase.
Gründker C; Völker P; Emons G
Endocrinology; 2001 Jun; 142(6):2369-80. PubMed ID: 11356684
[TBL] [Abstract][Full Text] [Related]
14. K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary.
Enomoto T; Weghorst CM; Inoue M; Tanizawa O; Rice JM
Am J Pathol; 1991 Oct; 139(4):777-85. PubMed ID: 1656759
[TBL] [Abstract][Full Text] [Related]
15. FOXL2 mutation and large-scale genomic imbalances in adult granulosa cell tumors of the ovary.
Geiersbach KB; Jarboe EA; Jahromi MS; Baker CL; Paxton CN; Tripp SR; Schiffman JD
Cancer Genet; 2011 Nov; 204(11):596-602. PubMed ID: 22200085
[TBL] [Abstract][Full Text] [Related]
16. Genetic analysis of mammalian G-protein signalling.
Offermanns S; Simon MI
Oncogene; 1998 Sep; 17(11 Reviews):1375-81. PubMed ID: 9779985
[TBL] [Abstract][Full Text] [Related]
17. The thyrotropin receptor (TSH-R) is not an oncogene for thyroid tumors: structural studies of the TSH-R and the alpha-subunit of Gs in human thyroid neoplasms.
Matsuo K; Friedman E; Gejman PV; Fagin JA
J Clin Endocrinol Metab; 1993 Jun; 76(6):1446-51. PubMed ID: 8501149
[TBL] [Abstract][Full Text] [Related]
18. Inhibin subunit gene expression in ovarian cancer.
Fuller PJ; Chu S; Jobling T; Mamers P; Healy DL; Burger HG
Gynecol Oncol; 1999 May; 73(2):273-9. PubMed ID: 10329046
[TBL] [Abstract][Full Text] [Related]
19. Activating point mutations of the gsp oncogene in human thyroid adenomas.
O'Sullivan C; Barton CM; Staddon SL; Brown CL; Lemoine NR
Mol Carcinog; 1991; 4(5):345-9. PubMed ID: 1910478
[TBL] [Abstract][Full Text] [Related]
20. Analysis of WT1 in granulosa cell and other sex cord-stromal tumors.
Coppes MJ; Ye Y; Rackley R; Zhao XL; Liefers GJ; Casey G; Williams BR
Cancer Res; 1993 Jun; 53(12):2712-4. PubMed ID: 8504409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
